Business Partnerships

At Nova Pharm – our innovation is driven by our enterprising and entrepreneurial appetite. We exhibit an ongoing desire and commitment to expand our portfolio, capitalise on market opportunities, and adapt to evolving regulatory environments. With an ever-increasing patient demand for affordable medications, Nova Pharm is strategically positioned to explore new avenues for growth—whether its through partnerships, acquisitions, licensing agreements, or the development of generic medication. This new business development focus is anchored in a commitment to innovation, cost-effectiveness, and compliance, alongside a keen understanding of Australasian market dynamics and consumer needs.

Private label manufacturing is a critical and integral part of our business. We boast over 18 years of experience in managing private label manufacturing for companies in Australia and abroad and our expertise in this area is broad ranging including but not limited to, managing change of batch size, improving costing profiles and adjustments to formulations. Through the number of products already registered in Australia and New Zealand, Nova boasts incredible experience in the process required for development, registration and marketing of both consumer and medicinal products.

Nova Pharm have an experienced in-house regulatory team, who can assist with all the change management processes, and a dedicated distribution team that can deliver the product to your doorstep. We currently have more than 200 registered products as well as over 100 planned products in the pipeline over the next 3 years, so are extremely well-positioned to leverage partnership opportunities.

Nova Pharm is always seeking collaborations with organisations who share a similar passion and ethos. We have forged strong strategic partnerships with other pharmaceutical companies and numerous leading suppliers over the years. We are the partner of choice with large-scale grocery giants and industry-leading pharmaceutical companies.

 

Strategic Considerations for ongoing New Business Development

• Therapeutic Areas: We choose to focus on medicinal areas with high-demand, low-competitive offerings, with chronic and prominent conditions as well as uniquely niche areas. These offer substantial market potential due to increasing prevalence and demand for affordable treatments.
• Biologics and Biosimilars: With the biosimilars market expected to grow rapidly as more biologics lose exclusivity, there is significant opportunity to develop and market biosimilar products, offering cost-effective alternatives to expensive biologic therapies.
• On-The-Shelf (OTS) & Over-the-Counter (OTC) Generics: Expanding into the over-the-counter generics market, where patient preference for cost-effective, easily accessible medications is growing, will help drive profitable revenue streams at scale.
• Advanced Drug Delivery Systems: Focusing on advanced generics with improved drug delivery systems, such as extended-release or targeted delivery, we believe will help to differentiate products and offer additional value to patients.